License is licensed 63 per cent effective against Avid-19, Kosovo will have access to it

The World Health Organization (OBSH) has approved two versions of the AstraZeneca/Oxford vaccine against coronavrus for urgent use. The vaccines will be available through the COVAX programme, part of which is Kosovo. Commenting on the global availability of vaccines, Deputy Director General of O BSH for Crying in Barna and Health Products, Dr. Mariangela Simao [...]
The vaccines will be available through the COVAX programme, part of which is Kosovo.
Commenting on the global availability of vaccines, Deputy Director General of O BSH for Crying in Barna and Health Products, Dr. Mariangeela Simao noted that all vaccine producers should increase production capacity and present their O-Accession vaccine candidates BSH's as soon as possible.
AstraZeneca is recommended for anyone over the age of 18.
“Vaxin has light saving requirements”, O added The BSH at a conference after the meeting, noting that vaccines with an efficiency of 63.09 will be “appropriate for low- and medium-income countries”.
Otherwise, Kosovo in December last year joined the global alliance “GAV I-COVAX”, which would enable her to access COVID-19 vaccine as soon as it is licensed.












